• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC, INC INVADER FACTOR V; IN-VITRO DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC, INC INVADER FACTOR V; IN-VITRO DIAGNOSTIC Back to Search Results
Catalog Number 95-453
Device Problems Incorrect, Inadequate or Imprecise Result or Readings (1535); Improper or Incorrect Procedure or Method (2017)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/29/2017
Event Type  Injury  
Event Description
(b)(6), customer, reported that they had discrepant results for three samples that were manually tested with the factor v assay.The customer ran a factor v assay with nine samples on (b)(6) 2017 using ln 189419, and all nine samples provided negative/homozygous wild type (wt) results.Results were reported out.After a single result from the run was questioned, the customer re-tested all nine samples on (b)(6) 2017 using ln 217190.It is not known whether the customer re-extracted the original samples prior to testing on (b)(6) 2017, or if the previously extracted samples from (b)(6) 2017 were re-tested on (b)(6) 2017.The re-testing provided six wt results, two carrier/heterozygous (het) results, and one homozygous mutant (mut) result.The customer stated that the discrepant results were likely caused by an operator error which impacted the original run performed on 10/4/17.The customer frequently tests the factor v and factor ii assays concurrently, on the same assay plate, using the same samples; so the customer believes the factor ii oligo mix was used for the factor v assay.Although the factor v assay was likely performed using the incorrect oligo mix, the assay was valid.It was emphasized to customer that the factor ii and factor v controls are not interchangeable.The controls from the factor v kit should be used with the factor v reagents and same for the factor ii controls and reagents.Customer inquired why the factor v controls would be valid in a factor v run performed with factor ii master mix.Hologic evaluated this issue and determined that factor v and factor ii assay controls do contain a mixture of both targets, but they are filled separately and labeled individually for each assay.Because of this, the assay controls should not be used interchangeably for both assays.When a factor v or factor ii assay is performed, a reaction mix is prepared using a universal buffer, universal enzyme mix, and an assay-specific oligo mix.The assay controls are intended to ensure that proper amplification occurs, but they do not control for severe operator errors such as preparing the factor v reaction mix using the factor ii oligo mix.Per hologic's risk assessment, the customer performed factor v testing with factor ii oligo mix, resulting in incorrect results.The severity associated with incorrect result is serious but the probability of incorrect results is remote.The final risk is assessed as 'as far as possible'.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVADER FACTOR V
Type of Device
IN-VITRO DIAGNOSTIC
Manufacturer (Section D)
HOLOGIC, INC
10210 genetic center dr.
san diego CA 92121
Manufacturer (Section G)
HOLOGIC, INC.
10210 genetic center dr.
san diego CA 92121
Manufacturer Contact
juliette busse
10210 genetic center dr.
san diego, CA 92121
8584108799
MDR Report Key7151944
MDR Text Key95963387
Report Number2024800-2017-00028
Device Sequence Number1
Product Code NPQ
UDI-Device Identifier15420045506664
UDI-Public15420045506664
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K100980
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 12/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/28/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number95-453
Device Lot Number189419
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received11/29/2017
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Outcome(s) Other;
-
-